Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

2.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.3K
Stimulants01:29

Stimulants

594
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
594
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

341
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
341
Ethical Issues01:27

Ethical Issues

1.6K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.6K
Drug Clearance: Overview01:06

Drug Clearance: Overview

243
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
243
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

632
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why we work with the tobacco industry.

Addiction (Abingdon, England)·2018
Same author

Abrupt versus gradual smoking cessation with pre-cessation nicotine replacement therapy for cigarette smokers motivated to quit.

Annals of translational medicine·2016
Same author

Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2011
Same author

[Recommendations for pharmacological tobacco cessation treatments: proposals for financing].

Archivos de bronconeumologia·2008
Same author

Intentions to quit smoking change over short periods of time.

Addictive behaviors·2005
Same author

Can reduced smoking be a way for smokers not interested in quitting to actually quit?

Respiration; international review of thoracic diseases·2005

Related Experiment Video

Updated: Nov 8, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

417

Closing Perspective on the Special Issue on JUUL.

Karl O Fagerström1

  • 1President, Fagerström Consulting AB, Stockholm, Sweden.

American Journal of Health Behavior
|April 25, 2021
PubMed
Summary

Electronic nicotine delivery systems (ENDS), like JUUL, present a regulatory challenge. Defining users and acceptable risks is crucial for balancing smoking cessation benefits against appeal to non-smokers.

Area of Science:

  • Public Health
  • Tobacco Control
  • Behavioral Science

Background:

  • Electronic Nicotine Delivery Systems (ENDS) are increasingly prevalent.
  • JUUL is a prominent ENDS product with unique characteristics.
  • The public health impact of ENDS, particularly JUUL, requires careful evaluation.

Purpose of the Study:

  • To provide an overview of a theme issue on ENDS, focusing on JUUL.
  • To evaluate ENDS as smoking cessation tools.
  • To assess the potential appeal of ENDS to non-smokers.

Main Methods:

  • Summarizing key findings from included research papers.
  • Offering an evaluative perspective on the dual role of ENDS.
  • Analyzing the complexities of defining user groups and acceptable risks.

More Related Videos

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.0K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.7K

Related Experiment Videos

Last Updated: Nov 8, 2025

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

417
Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
08:39

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

Published on: August 25, 2018

26.0K
Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

11.7K

Main Results:

  • Clear definitions of 'smoker' and 'non-smoker' are needed.
  • The acceptable level of unintended consequences versus harm reduction is debated.
  • Current data complicates conclusions on the public health role of ENDS/JUUL.

Conclusions:

  • Agreement on key definitions is essential for regulatory clarity.
  • Well-controlled studies are necessary to inform policy.
  • Developing a system to promote ENDS for smokers while discouraging use by never-smokers is a significant regulatory challenge.